(Q38100112)

28 August 2017

title

Tumour targeting with radiometals for diagnosis and therapy (English)

1 reference

28 August 2017

Caterina F Ramogida

1

1 reference

28 August 2017

Chris Orvig

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 May 2013

1 reference

28 August 2017

published in

Chemical Communications

1 reference

28 August 2017

volume

49

1 reference

28 August 2017

issue

42

1 reference

28 August 2017

page(s)

4720-4739

1 reference

Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

(99m)Tc-radiolabelled peptides for tumour imaging: present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

99mTc-centered one-pot synthesis for preparation of 99mTc radiotracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Molecular imaging with copper-64.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Molecular imaging with SPECT as a tool for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Targeted therapy using alpha emitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Targeted radiotherapy using Auger electron emitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Copper radionuclides and radiopharmaceuticals in nuclear medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

The development of copper radiopharmaceuticals for imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

In vivo biodistribution and accumulation of 89Zr in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Radiometals for combined imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Standardisation and decay data of 177Lu and 188Re

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

99m-Technetium carbohydrate conjugates as potential agents in molecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Cancer radioimmunotherapy with alpha-emitting nuclides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

The development of the alpha-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Towards translation of 212Pb as a clinical therapeutic; getting the lead in!

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Antibody-targeted radiation cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Radiometallated peptides for molecular imaging and targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

(S)-5-(p-nitrobenzyl)-PCTA, a promising bifunctional ligand with advantageous metal ion complexation kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Improved in vivo stability of actinium-225 macrocyclic complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Click-chemistry reactions in radiopharmaceutical chemistry: fast & easy introduction of radiolabels into biomolecules for in vivo imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Clickable bifunctional radiometal chelates for peptide labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

"Click-to-chelate": design and incorporation of triazole-containing metal-chelating systems into biomolecules of diagnostic and therapeutic interest

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Targeted therapies in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Spectrum of radiopharmaceuticals in nuclear oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Radiolabeled peptide-receptor ligands in tumor imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Nonnatural amino acids for site-specific protein conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Peptides as carrier for tumor diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Antibody vectors for imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

The advantages of nanoparticles for PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Radiopharmaceutical development of radiolabelled peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Criteria for the design and biological characterization of radiolabeled peptide-based pharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Rationale for the use of radiolabelled peptides in diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Radiolabelled RGD peptides for imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Gallium-68 complex of a macrobicyclic cage amine chelator tethered to two integrin-targeting peptides for diagnostic tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

(68)Ga-labeled radiopharmaceuticals for positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Peptide targeted copper-64 radiopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

PET imaging of tumor angiogenesis in mice with VEGF-A-targeted (86)Y-CHX-A″-DTPA-bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

Preparation of the Novel Chelating AgentN-(2-Aminoethyl)-trans-1,2-diaminocyclohexane-N,N‘,N‘‘-pentaacetic Acid (H5CyDTPA), a Preorganized Analogue of Diethylenetriaminepentaacetic Acid (H5DTPA), and the Structures of BiIII(CyDTPA)2-and BiIII(H

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CC41554F

21 January 2018

Identifiers

DOI

10.1039/C3CC41554F

1 reference

28 August 2017

1 reference